UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy

JNCI : Journal of the National Cancer Institute, 2009-02, Vol.101 (3), p.142-152

2009

Volltextzugriff (PDF)

Long-term update of the 24954 EORTC phase III trial on larynx preservation

European journal of cancer (1990), 2016-09, Vol.65, p.109-112

2016

Volltextzugriff (PDF)

Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: Results of a 2 x 2 randomised controlled trial

European journal of cancer (1990), 2011-05, Vol.47 (7), p.1027-1036

2011

Volltextzugriff (PDF)

Life-threatening interstitial lung disease associated with trastuzumab: case report

Breast cancer research and treatment, 2009-02, Vol.113 (3), p.609-612

2009

Volltextzugriff (PDF)

Economic evaluation of four follow-up strategies after curative treatment for breast cancer: Results of an RCT

European journal of cancer (1990), 2011-05, Vol.47 (8), p.1175-1185

2011

Volltextzugriff (PDF)

MIB-1 labelling index is an independent prognostic marker in primary breast cancer

British journal of cancer, 1998-08, Vol.78 (4), p.460-465

1998

Volltextzugriff (PDF)

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

The Lancet (British edition), 2014-06, Vol.383 (9935), p.2127-2135

2014

Volltextzugriff (PDF)

Molecular subtypes of breast cancer and amplification of topoisomerase IIα : predictive role in dose intensive adjuvant chemotherapy

British journal of cancer, 2006-11, Vol.95 (10), p.1334-1341

2006

Volltextzugriff (PDF)

Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer

Annals of oncology, 2006-04, Vol.17 (4), p.588-596

2006

Volltextzugriff (PDF)

Primary or secondary G-CSF prophylaxis to support TAC chemotherapy in breast cancer?

Annals of oncology, 2006-08, Vol.17 (8), p.1181-1183

2006

Volltextzugriff (PDF)

Follow-up after curative treatment for breast cancer: Why do we still adhere to frequent outpatient clinic visits?

European journal of cancer (1990), 2007-03, Vol.43 (4), p.647-653

2007

Volltextzugriff (PDF)

Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: Results of a 2 × 2 randomised controlled trial

European journal of cancer (1990), 2011-05, Vol.47 (7), p.1027-1036

2011

Volltextzugriff (PDF)

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Journal of clinical oncology, 2023-08, Vol.41 (23), p.3881-3890

2023

Volltextzugriff (PDF)

CD44v6 is not a prognostic factor in primary breast cancer

Annals of oncology, 1998-01, Vol.9 (1), p.109-111

1998

Volltextzugriff (PDF)

Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients

Bone marrow transplantation (Basingstoke), 2008-10, Vol.42 (7), p.475-481

2008

Volltextzugriff (PDF)

The role of chemotherapy in intracranial germinoma: A case report

Annals of oncology, 1999-06, Vol.10 (6), p.723-726

1999

Volltextzugriff (PDF)

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1413-1424

1999

Volltextzugriff (PDF)

505 Improving the quality and efficiency of breast cancer follow-up: results from an RCT

European journal of cancer supplements, 2010, Vol.8 (3), p.207-207

2010

Volltextzugriff (PDF)

High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer

The New England journal of medicine, 2003-07, Vol.349 (1), p.7-16

2003

Volltextzugriff (PDF)

Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1367-1376

1997

Volltextzugriff (PDF)

Prognostic significance of etiological risk factors in early breast cancer

Breast cancer research and treatment, 1997-05, Vol.43 (3), p.217-223

1997

Volltextzugriff (PDF)

Fatigue and Relating Factors in High-Risk Breast Cancer Patients Treated With Adjuvant Standard or High-Dose Chemotherapy: A Longitudinal Study

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8296-8304

2005

Volltextzugriff (PDF)

40LBA Results of an RCT investigating the cost-effectiveness of four follow-up strategies after breast cancer

European journal of cancer supplements, 2009, Vol.7 (3), p.18-18

2009

Volltextzugriff (PDF)

Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinoma

Annals of oncology, 1994-12, Vol.5 (10), p.957-960

1994

Volltextzugriff (PDF)

Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer

Anticancer research, 1998-11, Vol.18 (6A), p.4455

1998

Volltextzugriff (PDF)

1 – 25 von 74

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(74)

Sprache

Englisch
(68)
Niederländisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(51)
Female
(43)
Life Sciences & Biomedicine
(43)
Science & Technology
(43)
Middle Aged
(35)
Oncology
(34)
Adult
(31)
Biological And Medical Sciences
(31)
Medical Sciences
(29)
Aged
(28)
Tumors
(17)
Breast Cancer
(15)
Breast Neoplasms - Pathology
(15)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Breast Neoplasms - Drug Therapy
(14)
Male
(14)
Pharmacology. Drug Treatments
(14)
Follow-Up Studies
(13)
Gynecology. Andrology. Obstetrics
(13)
Mammary Gland Diseases
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy

Long-term update of the 24954 EORTC phase III trial on larynx preservation

Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: Results of a 2 x 2 randomised controlled trial

Life-threatening interstitial lung disease associated with trastuzumab: case report

Economic evaluation of four follow-up strategies after curative treatment for breast cancer: Results of an RCT

MIB-1 labelling index is an independent prognostic marker in primary breast cancer

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

Molecular subtypes of breast cancer and amplification of topoisomerase IIα : predictive role in dose intensive adjuvant chemotherapy

Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer

Primary or secondary G-CSF prophylaxis to support TAC chemotherapy in breast cancer?

Follow-up after curative treatment for breast cancer: Why do we still adhere to frequent outpatient clinic visits?

Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: Results of a 2 × 2 randomised controlled trial

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

CD44v6 is not a prognostic factor in primary breast cancer

Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients

The role of chemotherapy in intracranial germinoma: A case report

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

505 Improving the quality and efficiency of breast cancer follow-up: results from an RCT

High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer

Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer

Prognostic significance of etiological risk factors in early breast cancer

Fatigue and Relating Factors in High-Risk Breast Cancer Patients Treated With Adjuvant Standard or High-Dose Chemotherapy: A Longitudinal Study

40LBA Results of an RCT investigating the cost-effectiveness of four follow-up strategies after breast cancer

Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinoma

Relevance of the expression of bcl-2 in combination with p53 as a prognostic factor in breast cancer

Suchergebnisse filtern